| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Arog Pharmaceuticals (AROG) | Citigroup/ RBC Capital Market/ Nomura | $74.75 | n.a. | |||
| NGM Biopharmaceuticals (NGM) | Goldman Sachs/ Citigroup/ Cowen | $75.00 | n.a. | |||
| Niu Technologies (NIU) | Credit Suisse/ Citigroup | $150.00 | n.a. | |||
| Valtech SE (VTEC) | J.P. Morgan/ Morgan Stanley | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| Eagleline Acquisition (IGLEU) (u) | Stifel/ FBR/ Stephens | 15.00 | $10.00 | $10.00 | $150.00 | n.a. |
| New Terms | ||||||
| Alzheon (ALZH) | ThinkEquity (A division of Fordham Financial Management) | 2.50 | $13.00 | $15.00 | $35.00 | S/O |
| Elastic N.V. (ESTC) | Goldman Sachs/ J.P. Morgan/ Barclays/ RBC Capital Markets | 7.00 | $26.00 | $29.00 | $192.50 | S/O |
| Kodiak Sciences (KOD) | Morgan Stanley/ BofA Merrill Lynch | 9.00 | $13.00 | $15.00 | $126.00 | S/O |
| SharedLabs (SHLB) | ThinkEquity (a division of Fordham Financial Management) | 2.50 | $5.00 | $7.00 | $15.00 | S/O |
| Tiziana Life Sciences plc (TLSA) | Laidlaw & Company (UK) Ltd. | 1.58 | $10.25 | $10.25 | $16.14 | S/O |
| S/O (Subscribers Only) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Sept. 24, 2018 | Manager(s) | Offered | Raised | Price | 9/28/18 | Change |
| SVMK (SurveyMonkey) (SVMK) | J.P. Morgan/ Allen & Company/ BofA Merrill Lynch | 15.00 | $180.00 | $12.00 | $16.03 | 33.58% |
| Arco Platform (ARCE) | Goldman Sachs/ Morgan Stanley/ Itaú BBA/ BofA Merrill Lynch | 11.11 | $194.44 | $17.50 | $22.80 | 30.29% |
| Ra Medical (RMED) | Piper Jaffray/ Cantor | 3.90 | $66.30 | $17.00 | $18.20 | 7.06% |
| Arvinas (ARVN) | Goldman Sachs/ Citigroup/ Piper Jaffray | 7.50 | $120.00 | $16.00 | $16.87 | 5.44% |
| Capital Bancorp (CBNK) | Keefe, Bruyette & Woods (A Stifel Company)/ Stephens | 2.23 | $27.86 | $12.50 | $12.72 | 1.76% |
| LAIX Inc. (LAIX) | Morgan Stanley/ Goldman Sachs (Asia) | 5.75 | $71.88 | $12.50 | $12.55 | 0.40% |
| Viomi Technology (VIOT) | Morgan Stanley/ CICC | 11.40 | $102.60 | $9.00 | $9.00 | 0.00% |
| Sutro Biopharma (STRO) | Cowen/ Piper Jaffray | 5.67 | $85.01 | $15.00 | $15.00 | 0.00% |
| Gritstone Oncology (GRTS) | Goldman Sachs/ Cowen/ Barclays | 6.67 | $100.00 | $15.00 | $14.25 | -5.00% |
| Urovant Sciences (UROV) | J.P. Morgan/ Jefferies/ Cowen | 10.00 | $140.00 | $14.00 | $12.00 | -14.29% |
| CooTek (CTK) | Credit Suisse/ BofA Merrill Lych/ Citigroup | 4.35 | $52.20 | $12.00 | $9.44 | -21.33% |
| Entasis Therapeutics Holding (ETTX) | Credit Suisse/ BMO Capital Markets | 5.00 | $75.00 | $15.00 | $10.88 | -27.47% |
